Literature DB >> 11129315

The epidemiology of the genetic liability for schizophrenia.

J Hallmayer1.   

Abstract

OBJECTIVE: The low incidence of schizophrenia prohibits large scale prevention trials, and the question arises whether such studies become more feasible by taking into account genetic factors. The aim of the paper was to inform preventive endeavours with an account of the genetic background to schizophrenia.
METHOD: The family, twin and adoptive studies of schizophrenia are reviewed and recent molecular genetic data presented.
RESULTS: Children of a parent diagnosed with schizophrenia have a ten-fold increased risk of developing the disorder. Twin and adoption studies strongly suggest the risk increase is mainly due to genetic factors. On an individual level, a positive family history is the strongest known risk factor for schizophrenia. For a prevention study, very large numbers of families have to be screened in order to reach a sufficient sample size.
CONCLUSIONS: One obvious way to increase the accuracy of predicting who is at high risk of developing schizophrenia would be to find specific mutations in the human genome. Attempts to isolate specific genes by means of linkage and association studies have been unsuccessful so far and, given the number of genes involved, it is extremely unlikely that the predictive value of individual genes will be high enough to warrant intervention. Genetic studies also suggest the genetic liability extends beyond the traditional clinical phenotypes. Prevention trials might become possible by adopting a broader approach.

Entities:  

Mesh:

Year:  2000        PMID: 11129315     DOI: 10.1080/000486700222

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  4 in total

1.  Family aggregation of mental disorders in the nationwide Danish three generation study.

Authors:  Hans-Christoph Steinhausen; Leslie Foldager; Gurli Perto; Povl Munk-Jørgensen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-02-17       Impact factor: 5.270

Review 2.  Ethical issues in psychiatric genetics research: points to consider.

Authors:  Barbara Bowles Biesecker; Holly Landrum Peay
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

3.  Association between ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients.

Authors:  Yongfeng Yang; Wenqiang Li; Jingyuan Zhao; Hongxing Zhang; Xueqin Song; Bo Xiao; Ge Yang; Chengdi Jiang; Dai Zhang; Weihua Yue; Luxian Lv
Journal:  Behav Brain Funct       Date:  2012-02-28       Impact factor: 3.759

4.  DNA methylation and mRNA expression of SYN III, a candidate gene for schizophrenia.

Authors:  Brenda C Murphy; Richard L O'Reilly; Shiva M Singh
Journal:  BMC Med Genet       Date:  2008-12-22       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.